Hip replacement patients who thought they were safe from metal toxicity may still be at risk if they received one of the two Stryker hip components included in a nationwide recall on July 4, 2012. Some will need revision surgery to remove the implants due to associated problems, which include the potential for tissue damage and/or metallosis (metal poisoning).
Though the recall was more than a month ago, many patients could still be unaware of the recall status of their hip. The recalled devices include:
- Stryker Rejuvenate modular stems
- Stryker ABG II Modular stems
These hip replacement products were introduced amidst the movement away from “metal-on-metal” hips, which gained momentum following the DePuy ASR hip replacement recall in 2010. Because the recalled Stryker implants did not have metal-on-metal articulation at the site of the cup, they were represented as a safe alternative.
Professionals in the field have now discovered that the metal neck and stem units in the hip have the potential to corrode and “fret,” causing similar injuries to the metal-on-metal hip devices. For many recipients, the irony is overwhelmingly frustrating. Many had been aware of dangers associated with metal-on-metal hips and decided to proceed with these devices instead because they were not considered to be metal-on-metal devices.
Possible complications of Rejuvenate or ABG II devices (as reported by DrugWatch and included in Stryker’s own Safety Alert) include:
- Limited mobility
- Tissue inflammation
- The formation of tumors or pseudo-tumors
- Bone loss or dissolution
- Tissue death (necrosis)
- The need for one or more revisionary surgeries
Patients who received a Stryker hip implant should consult their physicians to assess their situation. These people may be eligible to bring a legal claim. If you have questions about the possibility of seeking compensation for the damage caused by a faulty medical device, seek the counsel of an experienced personal injury attorney in your area.